CTOs on the Move

Carlinville Area Hospital Association, Inc

www.cahcare.com

 
Carlinville Area Hospital Association, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Carlinville, IL. To find more information about Carlinville Area Hospital Association, Inc, please visit www.cahcare.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.cahcare.com
  • 1001 Morgan St
    Carlinville, IL USA 62626-1448
  • Phone: 217.854.3141

Executives

Name Title Contact Details

Similar Companies

Community Health Net Medical

Community Health Net offers a range of healthcare services for newborn through geriatric patients.

International Biometric Group

International Biometric Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WebOps

WebOps is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hutcheson Medical Center

Hutcheson Medical Center is one of the largest community hospitals in Georgia and has been recognized by the Georgia Alliance of Community Hospitals as one of the top community hospitals in Georgia several times.

BioSig Technologies

BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.